Physician profile
Ashley Michelle Leon
NPI 1235687260
$8,300.86
in general payments reported to CMS, 2019-2025
12 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,679 · 2022: $301 · 2023: $2,010 · 2024: $77.44 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117 · Honoraria: $1,000 · Travel and Lodging: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.95 |
| Honoraria | $1,000.00 |
| Travel and Lodging | $204.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,094.45 | 2021 | |
| G1 Therapeutics, INC. | $1,323.78 | 2023 | Cosela |
| Janssen Biotech, INC. | $842.40 | 2021-2025 | Erleada, Carvykti, Rybrevant |
| Astrazeneca Pharmaceuticals LP | $789.82 | 2021-2025 | Lynparza, Tagrisso, Imfinzi |
| Myriad Genetic Laboratories, INC. | $65.74 | 2023-2024 | Myrisk |
| Atricure, INC. | $46.97 | 2023 | |
| Emd Serono, INC. | $40.22 | 2022-2023 | Bavencio |
| Novartis Pharmaceuticals Corporation | $23.25 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.85 | 2022 | |
| Recordati_rare_diseases_inc. | $21.77 | 2024 | Sylvant |
| Seagen INC. | $15.62 | 2022 | |
| Puma Biotechnology, INC. | $14.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Leon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.